These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6411576)

  • 41. Infusion of human and canine factor VIII in dogs with von Willebrand's disease: studies of the von Willebrand and factor VIII synthesis stimulating factors.
    Bouma BN; Dodds WJ; van Mourik JA; Sixma JJ; Webster WP
    Scand J Haematol; 1976 Oct; 17(4):263-75. PubMed ID: 825957
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Electrophoretic heterogeneity of normal factor VIII/Von Willebrand protein, and abnormal electrophoretic mobility in patients with Von Willebrand's disease.
    Sultan Y; Simeon J; Caen JP
    J Lab Clin Med; 1976 Feb; 87(2):185-94. PubMed ID: 1082003
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Proteolytic activity of alpha 2-macroglobulin-enzyme complexes toward human factor VIII/von Willebrand factor.
    Switzer ME; Gordon HJ; McKee PA
    Biochemistry; 1983 Mar; 22(6):1437-44. PubMed ID: 6188490
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combined hemophilia A and type 2 von Willebrand's disease: defect of both factor VIII level and factor VIII binding capacity of von Willebrand factor.
    Casonato A; Pontara E; Sartorello F; Gemmati D; Cattini MG; Girolami A
    Haematologica; 2001 Oct; 86(10):1110-1. PubMed ID: 11602423
    [No Abstract]   [Full Text] [Related]  

  • 45. Diagnosis of von Willebrand's disease. A comparative study of diagnostic tests on nine families with von Willebrand's disease and its differential diagnosis from hemophilia and thrombocytopathy.
    Lian EC; Deykin D
    Am J Med; 1976 Mar; 60(3):344-56. PubMed ID: 1083143
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Von Willebrand factor and von Willebrand's disease: a complex protein and a complex disease.
    Bona RD
    Ann Clin Lab Sci; 1989; 19(3):184-9. PubMed ID: 2499240
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The spectrum of von Willebrand's disease revisited.
    Bowie EJ; Fass DN; Olson JD; Owen CA
    Mayo Clin Proc; 1976 Jan; 51(1):35-41. PubMed ID: 765637
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sulfatide-binding assay for von Willebrand factor. Detection of von Willebrand's disease without discrimination of vWD subtypes.
    Favaloro EJ
    Thromb Res; 2000 Apr; 98(2):213-9. PubMed ID: 10713323
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A new variant of von Willebrand's disease (type I Padua): doublet-organized plasma von Willebrand factor oligomers in the presence of all size multimers.
    Casonato A; Pontara E; Dannhäuser D; Bertomoro A; Sartori MT; Girolami A
    Haematologia (Budap); 1994; 26(2):97-109. PubMed ID: 7890268
    [TBL] [Abstract][Full Text] [Related]  

  • 50. On the discrepant post-DDAVP increase of FVIII:C and von Willebrand factor in some patients with severe von Willebrand's disease.
    Casonato A; Pontara E; Bertomoro A; Zucchetto A; Zerbinati A; Girolami A
    Br J Haematol; 1995 Oct; 91(2):512-3. PubMed ID: 8547104
    [No Abstract]   [Full Text] [Related]  

  • 51. Intranasal desmopressin (DDAVP) by spray in mild hemophilia A and von Willebrand's disease type I.
    Lethagen S; Harris AS; Nilsson IM
    Blut; 1990 Mar; 60(3):187-91. PubMed ID: 2107887
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Studies on the pathophysiology and treatment of von Willebrand's disease. VI. Variant von Willebrand's disease complicating placenta previa.
    Takahashi H
    Thromb Res; 1983 Jul; 31(2):285-96. PubMed ID: 6605595
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Factor VIII/von Willebrand factor in glomerular nephropathies.
    Coppola R; Guerra L; Ruggeri ZM; Tarantino A; Mannucci PM; Ponticelli C
    Clin Nephrol; 1981 Nov; 16(5):217-22. PubMed ID: 6796318
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Twenty-four hour variations of von Willebrand factor and factor VIII-related antigen in diabetic retinopathy.
    Porta M; Maneschi F; White MC; Kohner EM
    Metabolism; 1981 Jul; 30(7):695-9. PubMed ID: 6787387
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetics and hemostatic effect of different factor VIII/von Willebrand factor concentrates in von Willebrand's disease type III.
    Lethagen S; Berntorp E; Nilsson IM
    Ann Hematol; 1992 Dec; 65(6):253-9. PubMed ID: 1457586
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Factor VIII (coagulation activity VIII:C, antigen concentration VIIIR:Ag and von Willebrand factor) in patients with clinically expected intravascular coagulation].
    Tran TH; Lämmle B; Marbet UA; Ritz R; Marbet GA; Duckert F
    Schweiz Med Wochenschr; 1981 Oct; 111(41):1542-3. PubMed ID: 6797063
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An atypical von Willebrand's disease with hyperreactivity of platelet aggregation.
    Niiya K; Kubonishi I; Taguchi H; Miyoshi I
    Acta Haematol; 1984; 71(3):158-64. PubMed ID: 6424380
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Increased von Willebrand activity of low molecular-weight factor VIII following binding to gold granules].
    Furlan M; Perret BA; Beck EA
    Schweiz Med Wochenschr; 1980 Oct; 110(40):1456-8. PubMed ID: 6792697
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [A variant of the von Willebrand-Jürgens-syndrome with abnormalities of the factor VIII/von Willebrand factor protein (author's transl)].
    Hasler K; Böttcher D; Engelhardt R
    Blut; 1979 Jan; 38(1):25-34. PubMed ID: 310328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.